In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida now leads the nation in property insurance costs, with many homeowners paying more than $10,000 a year for shrinking coverage and higher deductibles. Despite nearly half of hurricane‑related claims ending with no payout and appeals failing over 90% of the time, state leaders say reforms “need more time to work.” With key relief bills stalled and real estate professionals feeling the shockwaves, experts warn that legislative inaction is deepening a crisis that threatens homeownership and the state’s economic stability.
Banks are finally calling in billions tied to troubled commercial real estate loans, pushing delinquency rates to historic highs and ending years of “extend and pretend.” With more than 12% of office loans now delinquent and $875 billion in commercial debt maturing in 2026, regional banks and property owners are facing mounting pressure. As valuations drop and refinancing becomes harder, experts warn that tighter lending standards and broader economic ripple effects are on the horizon—making strategic preparation essential for today’s real estate and finance professionals.
Florida policyholders are getting rare good news: the Florida Insurance Guaranty Association is ending its 1% emergency insurance assessment on October 1—two years ahead of schedule. The decision follows a calmer hurricane season, fewer insurer insolvencies, and growing market stability. The early termination is expected to save Floridians up to $650 million, with the average homeowner seeing about $31 in annual savings. This marks another milestone in the state’s insurance market recovery after major legislative reforms in 2022 and 2023.
The real estate industry has officially moved past its AI honeymoon phase. What began as a fun, optional tool has quietly become the backbone of how agents create content, communicate with clients, and market properties. But with that shift comes rising concern about authenticity, legal risks, and whether consumers will start questioning what they’re really paying agents for. As AI blends into everything from listing descriptions to client advice, professionals now face a new challenge: proving the human value behind the technology.
After years of volatility, industry analysts say commercial real estate may finally be on the verge of a major comeback. Investment activity is rising, leasing demand is strengthening, and key cities like Manhattan are leading a broader national recovery. With vacancy rates expected to drop and high‑quality buildings outperforming the rest, 2026 is shaping up to be the turning point investors and professionals have been waiting for.
AM Best warns that the property and casualty insurance market is heading into a more challenging 2026 as premium growth slows, inflation drives up claims costs, and combined ratios rise. Despite a strong 2025, moderating rates, higher repair and construction expenses, and ongoing reserve deficiencies are pressuring profitability. While commercial lines and personal lines both feel the strain, the E&S market continues to expand as traditional carriers pull back. This shifting landscape highlights the need for insurance professionals to stay sharp, informed, and adaptable.
